The 2000 EBCTCG overview: a widening gap

Lancet. 2005 May;365(9472):1665-6. doi: 10.1016/S0140-6736(05)66524-5.
No abstract available

Publication types

  • Comment

MeSH terms

  • Aged
  • Anthracyclines / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / mortality
  • Breast Neoplasms / therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Ovariectomy
  • Ovary / radiation effects
  • Receptors, Estrogen / analysis
  • Survival Rate
  • Tamoxifen / therapeutic use

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Tamoxifen